The Harv sure does have a way with words, doesn't he?
IF the enrolled patients are ALL living longer (or the placebo patients are living longer because of the overall patient population they picked - ones who have stopped progressing), then I guess people can throw all assumptions out the window.
Either way, I doubt very much Merck is delaying results on purpose.
Merck should know that The Harv will go to the shareholder "well" and dilute in massive amounts before succumbing to Merck.